Tempus ECG-Low EF vs CVI42
AI Verdict
Choose Tempus ECG-Low EF if…
Choose Tempus ECG-Low EF if your primary goal is rapid, AI-powered screening for signs of low left ventricular ejection fraction (LVEF ≤40%) using standard 12-lead ECGs. This tool is ideal for identifying patients 40 years or older at risk of heart failure who may require further diagnostic evaluation, particularly in high-volume clinical settings like emergency departments or primary care where quick triage is essential.
View Tempus ECG-Low EF →Choose CVI42 if…
Choose CVI42 if you require comprehensive, AI-enabled analysis of advanced cardiac and vascular imaging studies (CT and MRI) for detailed diagnosis, treatment planning, and patient care. This platform is best suited for specialized cardiology, cardiothoracic surgery, and radiology departments needing in-depth quantification of coronary plaque, advanced CMR automation, and 3D visualization for complex cases.
View CVI42 →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Tempus ECG-Low EF | CVI42 |
|---|---|---|
| Pricing | Unknown | Starts at $5,000 per license. |
| Deployment | Integrates with current ECG platforms and electronic health records (EHRs). | On-premise (standalone workstation or client/server) |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Tempus ECG-Low EFTempus ECG-Low EF (Tool A) offers a straightforward, binary output (Low LVEF Detected / Not Detected) and is designed for integration into existing healthcare facility workflows, suggesting a simpler user experience for a specific screening task. CVI42 (Tool B), while powerful, is a comprehensive platform for advanced imaging analysis, implying a steeper learning curve due to its extensive features and 3D visualization capabilities.
Clinical Value
TieBoth tools offer significant clinical value in different aspects of cardiovascular care. Tempus ECG-Low EF (Tool A) provides FDA-cleared AI analysis of ECGs for early detection of low LVEF, addressing a broad screening need for heart failure risk. CVI42 (Tool B) offers comprehensive, advanced diagnostic and planning tools for complex cardiac and vascular conditions using CT and MRI, providing deep insights for specialized cases.
Pricing & Value
CVI42While both tools require direct vendor contact for pricing, CVI42 (Tool B) offers more transparency by detailing a 'Flexible subscription that scales across CT and MR service lines' with additional licenses for specific modules. This provides a clearer understanding of its pricing model and potential scalability compared to Tempus ECG-Low EF's (Tool A) general 'contact vendor' statement.
Enterprise Readiness
Tempus ECG-Low EFTempus ECG-Low EF (Tool A) explicitly states it is HIPAA compliant, offers a Business Associate Agreement (BAA), and has FDA clearance, along with deployment integrated into healthcare workflows. CVI42 (Tool B) does not disclose BAA or HIPAA compliance in the provided facts, which is a critical factor for enterprise adoption in healthcare, despite having FDA clearance and DICOM/HL7 compatibility.
Innovation
CVI42While Tempus ECG-Low EF (Tool A) is innovative in applying AI to ECGs for LVEF detection, trained on a large dataset, CVI42 (Tool B) demonstrates a broader and deeper range of advanced AI applications across multiple complex imaging modalities. Its features include AI-automated coronary lumen and wall segmentation, comprehensive plaque analysis, advanced CMR automation, and research-use features like Pericoronary Adipose Tissue (PCAT) analysis.
Support & Docs
CVI42CVI42 (Tool B) provides extensive technical documentation, including user manuals for various software versions, installation guides, and DICOM/HL7 conformance statements. Furthermore, customer testimonials and satisfaction scores highlight its strong customer support. Tempus ECG-Low EF (Tool A) offers customer support via email and phone, but the level of detail regarding comprehensive documentation and explicit satisfaction metrics is less prominent in the available information.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Tempus ECG-Low EF | CVI42 |
|---|---|---|
| Name | Tempus ECG-Low EF | CVI42 |
| Company | Tempus AI | CIRCLE CARDIOVASCULAR IMAGING |
| Description | FDA-cleared AI software that analyzes 12-lead ECG recordings to detect signs associated with low left ventricular ejection fraction (LVEF u226440%) in patients 40 years or older at risk of heart failure. It provides a binary output to aid clinicians in further evaluation. | AI-enabled software platform for comprehensive cardiac and vascular imaging analysis, enhancing diagnosis, planning, and patient care with advanced CT and MRI tools. |
| Key Features | AI-powered algorithm for ECG analysis; Detects signs of low Left Ventricular Ejection Fraction (LVEF u226440%); Analyzes resting, non-ambulatory 12-lead ECG recordings; Provides a binary output (Low LVEF Detected / Not Detected); Aids in identifying patients 40+ years at risk of heart failure; Trained on a large dataset of over 930,000 ECGs from 170,000+ patients; Intended for use in clinical diagnostic settings at healthcare facilities | AI-automated coronary lumen and wall segmentation; Comprehensive coronary plaque analysis (calcified, non-calcified, low-attenuation); Advanced CMR automation (T1 mapping, 4D flow pre-processing); Vascular CT analysis and planning tools; Automated detection of suspected coronary lesions; Pericoronary Adipose Tissue (PCAT) analysis (research use only); 3D visualization and image fusion; Automated contouring of regions of interest |
| Specialties | Cardiology, Emergency Medicine, Internal Medicine | Cardiology, Cardiothoracic Surgery, Radiology |
Videos
Demos, reviews, and walkthroughs featuring Tempus ECG-Low EF and CVI42.
Frequently Asked Questions
More Comparisons
More matchups featuring Tempus ECG-Low EF or CVI42
Backers
Who funded each tool's parent company.